Surgical Innovations (SUN) Stock Statistics & Valuation Metrics

Surgical Innovations has a market cap or net worth of £6.53M. The enterprise value is 7.57M.

Surgical Innovations has 932,816,160 shares outstanding. The number of shares has decreased by -2.65% in one year.

Surgical Innovations’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -7.54%.

The current PE Ratio of Surgical Innovations is -2.64. Surgical Innovations’s PEG ratio is 0.01.

In the last 12 months, Surgical Innovations had revenue of 11.95M and earned -1.94M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -74.00K and capital expenditures -67.00K, giving a free cash flow of -141.00K billion.

Surgical Innovations pays an annual dividend of ―, resulting in a dividend yield of ―

Surgical Innovations upcoming earnings date is Sep 23, 2025, TBA (Confirmed).

Surgical Innovations as a current ratio of 1.88, with Debt / Equity ratio of 14.52%

In the past 12 months, Surgical Innovations has paid -107.00K in taxes.

Surgical Innovations EV to EBITDA ratio is -62.38, with an EV/FCF ratio of -15.10.

Surgical Innovations has £195.00K in cash and marketable securities with £1.24M in debt, giving a net cash position of £1.04M billion.

Gross margin is 28.77%, with operating margin of -6.62%, and net profit margin of -16.27%.

The average price target for Surgical Innovations is ―, which is 11.43% higher than the current price. The consensus rating is ―